Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Show more...
FAQ
Agios Pharmaceuticals 今天的股价是多少?▼
AGIO 当前价格为 $28.16 USD,过去 24 小时上涨了 +2.62%。在图表上更密切关注 Agios Pharmaceuticals 股价表现。
Agios Pharmaceuticals 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Agios Pharmaceuticals 的股票以代码 AGIO 进行交易。
Agios Pharmaceuticals 的股价在上涨吗?▼
AGIO 股票较上周下跌 -1.78%,本月上涨 +3.61%,过去一年 Agios Pharmaceuticals 下跌 -16.23%。
Agios Pharmaceuticals 的市值是多少?▼
今天 Agios Pharmaceuticals 的市值为 1.64B
Agios Pharmaceuticals 下一次财报日期是什么时候?▼
Agios Pharmaceuticals 将于 二月 12, 2026 发布下一次财报。
Agios Pharmaceuticals 上一季度的财报怎么样?▼
AGIO 上季度财报为每股 -1.78 USD,预估为 -1.9 USD,带来 +6.14% 的意外。下季度预估财报为每股 不适用 USD。
Agios Pharmaceuticals 去年的营收是多少?▼
Agios Pharmaceuticals 去年的营收为 73MUSD。
Agios Pharmaceuticals 去年的净利润是多少?▼
AGIO 去年的净收益为 1.35BUSD。
Agios Pharmaceuticals 有多少名员工?▼
截至二月 03, 2026,公司共有486名员工。
Agios Pharmaceuticals 属于哪个行业?▼
Agios Pharmaceuticals从事于Health Care行业。
Agios Pharmaceuticals 何时完成拆股?▼
Agios Pharmaceuticals 最近没有进行任何拆股。
Agios Pharmaceuticals 的总部在哪里?▼
Agios Pharmaceuticals 的总部位于 US 的 Cambridge。